Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-Results Survey of Graceptor® Capsules 0.5mg, 1 mg, and 5 mg in Kidney Transplant Patients

NCT02160054 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02160054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02160054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-Results Survey of Graceptor® Capsules 0.5mg, 1 mg, and 5 mg in Kidney Transplant Patients
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
November 15, 2013
Completion date
March 31, 2016
Enrollment
289 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

the maintenance phase after kidney transplantation